March 20, 2009

Obama Moves to Protect Science From Politics 

Early last week, President Obama issued a memo aimed at restoring scientific integrity to policymaking. The memo was signed at the same ceremony as and released jointly with the executive order expanding the availability of federal funds for embryonic stem cell research. During his address before signing the memorandum, the President placed the stem cell issue squarely within the larger context of de-politicizing science.

More Details >


Mary Hendrix Testifies for Increased NIH Funding

 

Nationally recognized cancer researcher and former FASEB Board President Dr. Mary Hendrix testified on behalf of the Ad Hoc Group for Medical Research at a March 18th House Labor, Health & Human Services (LHHS) Appropriations Subcommittee hearing on the Fiscal Year (FY) 2010 budget. Commending Congress and LHHS Subcommittee Chairman David Obey (D-WI) for the significant investment in medical research that was included in the FY 2009 omnibus appropriations bill (Public Law 111-8) and the American Recovery and Reinvestment Act (ARRA – Public Law 111-5), Dr. Hendrix urged the subcommittee to increase funding for NIH in FY 2010 by at least seven percent. Explaining the rationale behind the requested increase, Dr. Hendrix indicated that keeping up with the rising cost of medical research in the 2010 appropriations bill will help NIH begin to prepare for the “post-stimulus” era and is a critical step towards resuming a steady, sustainable growth that will enable researchers to complete the President’s vision of doubling the investment in basic research.

 

More Details >


FASEB Praises President for Lifting Restrictions on Stem Cell Research



Fulfilling a promise he made on the campaign trail last year, President Barack Obama issued an Executive Order on March 9th overturning the existing restrictions on human stem cell research that were adopted by

the Bush administration in August 2001. The new policy permits federal funding to be used for embryonic stem cell research and instructs the National Institutes of Health (NIH) to develop new guidelines within 120 days to assure that the research will meet the highest ethical standards.

 

More Details >


Inside (The Beltway) Scoop

After adopting another temporary “continuing resolution” that allowed for several additional days of debate, the U.S. Senate finally passed the FY 2009 omnibus appropriations bill (HR 1105) the evening of March 10th by a voice vote. Final adoption of the legislation came after more than 20 amendments were defeated, mostly along partisan lines. President Obama quietly signed the bill into law (Public Law 111-008) on March 11th, bringing the FY 2009 appropriations cycle to a close six months in to new the fiscal year.

More Details >


House Committee Holds Science Accountable for Stimulus Funds

Yesterday, the House Science and Technology Committee Investigations and Oversight Subcommittee held a hearing featuring two panels of representatives from science agencies under the committee’s jurisdiction to discuss accountability, transparency and oversight within each agency with respect to the funds from the American Recovery and Reinvestment Act (ARRA). The hearing, "Follow the Money: Accountability and Transparency in Recovery Act Science Funding," featured testimony from the “senior accountability officers” and Inspectors General (IGs) from the National Science Foundation (NSF), Department of Energy (DOE), Commerce Department and National Aeronautics and Space Administration (NASA). The tone of the hearing was probative if generally supportive.

More Details >

 


Energy Secretary Chu Testifies at Senate Hearings

Over the past month, Energy Secretary Steven Chu has appeared several times before Congress to discuss the budget, goals, and structure of the Department of Energy (DOE). His most recent appearance was at a hearing of the House Committee on Science and Technology, where, during a discussion of DOE plans and oversight for spending Recovery Act funds, Chairman Bart Gordon (D-TN) remarked, “The funding will make critical investments in a wide range of activities spanning the innovation spectrum from basic research to supporting the market for new energy technologies.” He added, “It presents a historic opportunity to put people to work building a more sustainable future for the country. However, when it comes to the taxpayers’ money we must work together to ensure these funds are spent wisely.”

 

More Details >

 

 


Holdren and Lubchenco Confirmed

Yesterday, John P. Holdren, Ph. D., President Obama’s nominee to lead the White House Office of Science and Technology Policy (OSTP), and Jane Lubchenco, Ph.D., nominated to be Undersecretary of Commerce for Oceans and Atmosphere at the U.S. Department of Commerce (also known as the Administrator of the National Oceanic and Atmospheric Administration - NOAA), were finally confirmed by the Senate by a vote of 61 to 31. The confirmation came after a protracted and confusing series of delays that raised the ire of some in the scientific community.

 

More Details >

 


FASEB Encourages OMB to Reduce Regulatory Burden

FASEB sent a letter to the Office of Management and Budget (OMB) urging a reduction in the regulatory burden shouldered by the scientific community. The letter was submitted in response to an OMB request for information intended to inform the development of a set of recommendations for a new Executive Order on federal regulatory review. Responding to a directive from President Obama, OMB’s recommendations are to offer suggestions related to the disclosure and transparency of regulations, the role of cost-benefit analysis in the development of regulations, public participation in agency regulatory processes, and identification of methods to ensure that regulatory review does not produce undue delay, among other issues.

 

More Details >

 

 

 

 


FASEB’s Washington Update is brought to you bi-monthly by the FASEB Office of Public Affairs. We welcome your questions and comments – please contact Jennifer Zeitzer at jzeitzer@faseb.org or 301-634-7650. For more information about how to get involved in research advocacy, visit: http://capwiz.com/faseb/home/

 

   
   
 

Click Here to
Subscribe/Unsubscribe to FASEB Washington Update